Atlas Trials

Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

Clinical trial NCT02834507 · COMPLETED

Trial details

NCT number
NCT02834507
Sponsor
Bial - Portela C S.A.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson's Disease (PD)
Start date
2005-03-01
Primary completion
2005-11-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.